Skip to Content

Join the 'Hidradenitis Suppurativa' group to help and get support from people like you.

Hidradenitis Suppurativa News

FDA Approves Humira (adalimumab) for Moderate to Severe Hidradenitis Suppurativa

Posted 11 Sep 2015 by Drugs.com

NORTH CHICAGO, Ill., Sept. 10, 2015 /PRNewswire/ – AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Humira (adalimumab) for the treatment of moderate to severe hidradenitis suppurativa (HS). Humira is now the first and only FDA-approved therapy for adults with HS. Hidradenitis suppurativa is a chronic inflammatory ...

Ask a Question

Further Information

Related Condition Support Groups

Dermatological Disorders

Related Drug Support Groups

Humira, adalimumab